Jodie L Babitt, Michele F Eisenga, Volker H Haase, Abhijit V Kshirsagar, Adeera Levin, Francesco Locatelli, Jolanta Małyszko, Dorine W Swinkels, Der-Cherng Tarng, Michael Cheung, Michel Jadoul, Wolfgang C Winkelmayer, Tilman B Drüeke
In chronic kidney disease, anemia and disordered iron homeostasis are prevalent and associated with significant adverse consequences. In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) issued an anemia guideline for managing the diagnosis, evaluation, and treatment of anemia in chronic kidney disease. Since then, new data have accrued from basic research, epidemiological studies, and randomized trials that warrant a re-examination of previous recommendations. Therefore, in 2019, KDIGO decided to convene 2 Controversies Conferences to review the latest evidence, explore new and ongoing controversies, assess change implications for the current KDIGO anemia guideline, and propose a research agenda...
June 2021: Kidney International